This trial will evaluate the rate of a type of stent called a Hydrus Microstent malposition and its associated clinical problems that occur within 24 months post-operation.
3 Primary · 7 Secondary · Reporting Duration: 24 Months
Experimental Treatment
545 Total Participants · 1 Treatment Group
Primary Treatment: Hydrus Microstent · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: